Infantile Spasms Therapeutics Market by Therapeutic Class (Anticonvulsants, Corticosteroids, and Others), Drug Type (Vigabatrin, Adrenocorticotropic Hormone, and Others (Phase III)), Dosage (Solid, Liquid), Route of Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End User (Hospitals, Clinics, and Others), and Region 2024-2032

Infantile Spasms Therapeutics Market by Therapeutic Class (Anticonvulsants, Corticosteroids, and Others), Drug Type (Vigabatrin, Adrenocorticotropic Hormone, and Others (Phase III)), Dosage (Solid, Liquid), Route of Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End User (Hospitals, Clinics, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A6789
Buy Now

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Infantile Spasms Therapeutics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Therapeutic Class
    6.1    Anticonvulsants
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Corticosteroids
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Others
        6.3.1 Market Trends
        6.3.2 Market Forecast
7    Market Breakup by Drug Type
    7.1    Vigabatrin
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Adrenocorticotropic Hormone
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Others (Phase III)
        7.3.1 Market Trends
        7.3.2 Market Forecast
8    Market Breakup by Dosage 
    8.1    Solid
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Liquid
        8.2.1 Market Trends
        8.2.2 Market Forecast
9    Market Breakup by Route of Administration
    9.1    Oral
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Parenteral
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10    Market Breakup by Distribution Channel
    10.1    Hospital Pharmacy
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2    Retail Pharmacy
        10.2.1 Market Trends
        10.2.2 Market Forecast
    10.3    Online Pharmacy
        10.3.1 Market Trends
        10.3.2 Market Forecast
11    Market Breakup by End User
    11.1    Hospitals
        11.1.1 Market Trends
        11.1.2 Market Forecast
    11.2    Clinics
        11.2.1 Market Trends
        11.2.2 Market Forecast
    11.3    Others
        11.3.1 Market Trends
        11.3.2 Market Forecast
12    Market Breakup by Region
    12.1    North America
        12.1.1 United States
           12.1.1.1 Market Trends
           12.1.1.2 Market Forecast
        12.1.2 Canada
           12.1.2.1 Market Trends
           12.1.2.2 Market Forecast
    12.2    Asia-Pacific
        12.2.1 China
           12.2.1.1 Market Trends
           12.2.1.2 Market Forecast
        12.2.2 Japan
           12.2.2.1 Market Trends
           12.2.2.2 Market Forecast
        12.2.3 India
           12.2.3.1 Market Trends
           12.2.3.2 Market Forecast
        12.2.4 South Korea
           12.2.4.1 Market Trends
           12.2.4.2 Market Forecast
        12.2.5 Australia
           12.2.5.1 Market Trends
           12.2.5.2 Market Forecast
        12.2.6 Indonesia
           12.2.6.1 Market Trends
           12.2.6.2 Market Forecast
        12.2.7 Others
           12.2.7.1 Market Trends
           12.2.7.2 Market Forecast
    12.3    Europe
        12.3.1 Germany
           12.3.1.1 Market Trends
           12.3.1.2 Market Forecast
        12.3.2 France
           12.3.2.1 Market Trends
           12.3.2.2 Market Forecast
        12.3.3 United Kingdom
           12.3.3.1 Market Trends
           12.3.3.2 Market Forecast
        12.3.4 Italy
           12.3.4.1 Market Trends
           12.3.4.2 Market Forecast
        12.3.5 Spain
           12.3.5.1 Market Trends
           12.3.5.2 Market Forecast
        12.3.6 Russia
           12.3.6.1 Market Trends
           12.3.6.2 Market Forecast
        12.3.7 Others
           12.3.7.1 Market Trends
           12.3.7.2 Market Forecast
    12.4    Latin America
        12.4.1 Brazil
           12.4.1.1 Market Trends
           12.4.1.2 Market Forecast
        12.4.2 Mexico
           12.4.2.1 Market Trends
           12.4.2.2 Market Forecast
        12.4.3 Others
           12.4.3.1 Market Trends
           12.4.3.2 Market Forecast
    12.5    Middle East and Africa
        12.5.1 Market Trends
        12.5.2 Market Breakup by Country
        12.5.3 Market Forecast
13    Drivers, Restraints, and Opportunities
    13.1    Overview
    13.2    Drivers
    13.3    Restraints
    13.4    Opportunities
14    Value Chain Analysis
15    Porters Five Forces Analysis

    15.1    Overview
    15.2    Bargaining Power of Buyers
    15.3    Bargaining Power of Suppliers
    15.4    Degree of Competition
    15.5    Threat of New Entrants
    15.6    Threat of Substitutes
16    Price Analysis
17    Competitive Landscape

    17.1    Market Structure
    17.2    Key Players
    17.3    Profiles of Key Players
        17.3.1    H. Lundbeck A/S
           17.3.1.1 Company Overview
           17.3.1.2 Product Portfolio
           17.3.1.3 Financials
           17.3.1.4 SWOT Analysis
        17.3.2    Mallinckrodt plc
           17.3.2.1 Company Overview
           17.3.2.2 Product Portfolio
           17.3.2.3 Financials
        17.3.3    ORPHELIA Pharma
           17.3.3.1 Company Overview
           17.3.3.2 Product Portfolio
        17.3.4    Teva Pharmaceuticals USA Inc. (Teva Pharmaceutical Industries Ltd.)
           17.3.4.1 Company Overview
           17.3.4.2 Product Portfolio

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

Figure 1: Global: Infantile Spasms Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018-2023
Figure 3: Global: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 4: Global: Infantile Spasms Therapeutics Market: Breakup by Therapeutic Class (in %), 2023
Figure 5: Global: Infantile Spasms Therapeutics Market: Breakup by Drug Type (in %), 2023
Figure 6: Global: Infantile Spasms Therapeutics Market: Breakup by Dosage (in %), 2023
Figure 7: Global: Infantile Spasms Therapeutics Market: Breakup by Route of Administration (in %), 2023
Figure 8: Global: Infantile Spasms Therapeutics Market: Breakup by Distribution Channel (in %), 2023
Figure 9: Global: Infantile Spasms Therapeutics Market: Breakup by End User (in %), 2023
Figure 10: Global: Infantile Spasms Therapeutics Market: Breakup by Region (in %), 2023
Figure 11: Global: Infantile Spasms Therapeutics (Anticonvulsants) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Infantile Spasms Therapeutics (Anticonvulsants) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Infantile Spasms Therapeutics (Corticosteroids) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Infantile Spasms Therapeutics (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Infantile Spasms Therapeutics (Other Therapeutic Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Infantile Spasms Therapeutics (Other Therapeutic Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Infantile Spasms Therapeutics (Vigabatrin) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Infantile Spasms Therapeutics (Vigabatrin) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Infantile Spasms Therapeutics (Adrenocorticotropic Hormone) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Infantile Spasms Therapeutics (Adrenocorticotropic Hormone) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Infantile Spasms Therapeutics (Other Drug Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Infantile Spasms Therapeutics (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Infantile Spasms Therapeutics (Solid) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Infantile Spasms Therapeutics (Solid) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Infantile Spasms Therapeutics (Liquid) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Infantile Spasms Therapeutics (Liquid) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Infantile Spasms Therapeutics (Oral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Infantile Spasms Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Infantile Spasms Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Infantile Spasms Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Infantile Spasms Therapeutics (Other Routes of Administration) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Infantile Spasms Therapeutics (Other Routes of Administration) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Infantile Spasms Therapeutics (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Infantile Spasms Therapeutics (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Infantile Spasms Therapeutics (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Infantile Spasms Therapeutics (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: Infantile Spasms Therapeutics (Online Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: Infantile Spasms Therapeutics (Online Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Global: Infantile Spasms Therapeutics (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Global: Infantile Spasms Therapeutics (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Global: Infantile Spasms Therapeutics (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Global: Infantile Spasms Therapeutics (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Global: Infantile Spasms Therapeutics (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Global: Infantile Spasms Therapeutics (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: North America: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: North America: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: United States: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: United States: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Canada: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Canada: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Asia-Pacific: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Asia-Pacific: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: China: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: China: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Japan: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Japan: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: India: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: India: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: South Korea: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: South Korea: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Australia: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Australia: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Indonesia: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Indonesia: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Others: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Others: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Europe: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Europe: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Germany: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Germany: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: France: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: France: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: United Kingdom: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: United Kingdom: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Italy: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Italy: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Spain: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Spain: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Russia: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Russia: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Others: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Others: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Latin America: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Latin America: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Brazil: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: Brazil: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Mexico: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 88: Mexico: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 89: Others: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 90: Others: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 91: Middle East and Africa: Infantile Spasms Therapeutics Market: Sales Value (in Million US$), 2018 & 2023
Figure 92: Middle East and Africa: Infantile Spasms Therapeutics Market: Breakup by Country (in %), 2023
Figure 93: Middle East and Africa: Infantile Spasms Therapeutics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 94: Global: Infantile Spasms Therapeutics Industry: Drivers, Restraints, and Opportunities
Figure 95: Global: Infantile Spasms Therapeutics Industry: Value Chain Analysis
Figure 96: Global: Infantile Spasms Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Infantile Spasms Therapeutics Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Infantile Spasms Therapeutics Market Forecast: Breakup by Therapeutic Class (in Million US$), 2024-2032
Table 3: Global: Infantile Spasms Therapeutics Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
Table 4: Global: Infantile Spasms Therapeutics Market Forecast: Breakup by Dosage (in Million US$), 2024-2032
Table 5: Global: Infantile Spasms Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 6: Global: Infantile Spasms Therapeutics Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 7: Global: Infantile Spasms Therapeutics Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 8: Global: Infantile Spasms Therapeutics Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 9: Global: Infantile Spasms Therapeutics Market: Competitive Structure
Table 10: Global: Infantile Spasms Therapeutics Market: Key Players

Infantile Spasms Therapeutics Market by Therapeutic Class (Anticonvulsants, Corticosteroids, and Others), Drug Type (Vigabatrin, Adrenocorticotropic Hormone, and Others (Phase III)), Dosage (Solid, Liquid), Route of Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End User (Hospitals, Clinics, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More